Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The p53 tumor suppressor is crucial for cancer prevention through complex apoptotic functions.
• p53 acts as a transcriptional activator and directly induces apoptosis via mitochondrial pathways.
• Mitochondrial targeting of p53 shows promise in p53-null tumors.

Purpose of the Study:

• To investigate the efficacy of mitochondrially targeted p53 in tumors with missense p53 mutations.
• To determine if p53's direct mitochondrial proapoptotic role is effective against common p53 alterations.

Main Methods:

• Developing mitochondrially targeted p53 constructs.
• Utilizing B-lymphoma models with various p53 point mutants.
• Assessing tumor growth, apoptosis induction in vitro and in vivo in mice.

Main Results:

• Mitochondrially targeted p53 significantly inhibited B-lymphoma growth in mice.
• Targeted p53 induced efficient apoptosis in vitro and in vivo.
• This approach demonstrated efficacy even in tumors with diverse p53 missense mutants.

Conclusions:

• Targeting p53 to mitochondria is a viable strategy for suppressing tumor growth, irrespective of p53 mutation status.
• This approach leverages p53's direct mitochondrial apoptotic function against a broad spectrum of human cancers.
• Mitochondrial p53 delivery represents a novel therapeutic avenue for p53-mutated malignancies.